Skip to main content
. 2016 Dec 15;6(2):175–180. doi: 10.3892/br.2016.828

Figure 2.

Figure 2.

Changes from baseline of the GERD scores following administration of 20 mg VPZ once daily for 4 weeks in patients with NERD. The GERD scores at baseline and after 4 weeks of VPZ therapy in NERD patients were 7.0±1.6 and 3.9±2.0, and this difference was statistically significant (*P<0.01). GERD, gastroesophageal reflux disease; VPZ, vonoprazan; NERD, non-erosive reflux disease; PCAB, potassium-competitive acid blocker.